CVRx, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
CVRX on Nasdaq
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, MN

Insiders trading volume in the past year

CVRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Johnson & Johnson 10%+ Owner $40.5M -$546K -1.33% Nov 12, 2025
Johnson & Johnson Innovation - JJDC, Inc. 10%+ Owner $13.8M Sep 15, 2023
Kirk G. Nielsen Director $10.6M +$1.04M +10.9% Jun 3, 2025
New Enterprise Associates 10 L P 10%+ Owner $8.01M Jul 2, 2021
Geoffrey B. Pardo Director $7.29M Jul 2, 2021
Mudit K. Jain Director $5.95M +$7.78K +0.13% Jun 3, 2025
GSK plc 10%+ Owner $3.98M Jul 2, 2021
Kevin Hykes PRES & CEO, Director $1.4M +$24.2K +1.75% May 12, 2025
Robert Allen John Chief Revenue Officer $942K Feb 28, 2025
Nea Partners 10 L P 10%+ Owner $686K Jul 2, 2021
Jared Oasheim Chief Financial Officer $678K Feb 28, 2025
Philip B. Adamson Chief Medical Officer $426K Feb 28, 2025
Joseph P. Slattery Director $388K Jun 3, 2025
Paul Verrastro Chief Mktg & Strat Officer $352K -$19.4K -5.23% Feb 28, 2025
John M. Nehra Director $251K Jun 7, 2022
Ding Dean Bruhn Vp Of Reg. Affairs And Qa $247K Aug 2, 2022
Nadim Yared CHIEF EXECUTIVE OFFICER, Director $217K Feb 2, 2024
Kevin J. Ballinger Director $186K Jun 3, 2025
Mitch C. Hill Director $186K Jun 3, 2025
Ali Behbahani Director $141K Jun 4, 2024
Martha Shadan Director $140K Jun 3, 2025
John Brintnall Chief Strategy Officer And Sec $125K Apr 22, 2022
Brent Binkowski Chief Operating Officer $114K Aug 11, 2025
Craig E. Palmer Svp, U.S. Sales $6.32K Mar 25, 2024
Liz Galle Vp Of Global Clinical Research $3.08K Oct 16, 2023

Recent Insider Transactions by Companies or Individuals for CVRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.